Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

Fri, 01st Dec 2023 08:52

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

The FTSE 100 index opened up 47.91 points, 0.6%, at 7,501.66. The FTSE 250 was up 34.99 points, 0.2%, at 18,268.46, and the AIM All-Share was up 0.51 of a point, 0.1%, at 714.29.

The Cboe UK 100 was up 0.7% at 748.20, the Cboe UK 250 was virtually flat at 15,767.16, and the Cboe Small Companies was up 0.1% at 13,345.06.

In early economic news, data from Nationwide showed that the annual pace of decline in UK house prices eased somewhat in November, as house prices rose on a monthly basis.

On a seasonally-adjusted basis, UK house prices rose by 0.2% in November from October, with growth slowing slightly from a 0.9% on-month rise in October.

On an annual basis, prices were 2.0% lower in November, slowing from the 3.3% fall in October.

"There has been a significant change in market expectations for the future path of Bank Rate in recent months which, if sustained, could provide much needed support for housing market activity," said Robert Gardner, Nationwide's chief economist.

London-listed housebuilders were marginally higher following the data. Berkeley Group was up 1.1%, Persimmon rose by 0.4% and Taylor Wimpey was up 0.7%.

So far on Friday morning, there have been manufacturing purchasing managers' index readings from China, Ireland and Japan. The results were a mixed bag, with manufacturing conditions deteriorating in Japan, halting in Ireland, and improving in China.

In China, the Caixin manufacturing purchasing managers' index rose to a three-month high of 50.7 points last month from 49.5 in October. The reading above 50 points indicates growth in the sector.

"Demand continued to grow, as the gauge for new orders remained in expansionary territory for the fourth consecutive month, hitting the highest since June," said Wang Zhe, senior economist at Caixin Insight Group. "Compared with consumer goods and intermediate goods, the supply and demand of investment goods were weaker.

The positive data boosted mining stocks in London. Anglo American jumped 4.3%, Rio Tinto rose 2.4%, and Antofagasta was up 2.0%, and Glencore rose 1.8%.

Brent oil was quoted at USD80.61 a barrel early in London on Friday, down from USD80.56 late Thursday.

The economic calendar still has a slew of manufacturing PMI releases, including for the EU, the UK and the US.

Elsewhere on the FTSE 100, AstraZeneca was up 1.7%.

AstraZeneca has decided to discontinue the Stabilize-ckd and Dialize-Outcomes Phase III evidence trials for Lokelma, sodium zirconium cyclosilicate.

The decision was made due to substantially increased enrolment timelines and low event rates, respectively, which made it prohibitive to deliver study results within a timeframe to meaningfully advance clinical practice.

They are part of the Crystalize evidence programme, which researches the benefit of Lokelma in the management of hyperkalaemia across the cardiorenal spectrum.

In the FTSE 250 index, Ceres Power plummeted 20%.

After market close on Thursday, the clean energy technology developer issued a trading update.

It said it expects 2023 revenue to be around GBP20 million to GBP21 million, down from GBP22 million in 2022. Ceres noted that this is because it it is unlikely it will sign an agreement with "the most imminent of the new licensees" in time for the associated revenue to be recognised in 2023, despite an agreement "progressing well".

Chief Executive Phil Caldwell commented: "Despite good progress commercially and growing interest in our SOEC technology, we have not been able to conclude a new license partnership in this financial year. We remain confident of securing a new commercial partnership in the coming months and we will provide a year-end trading update in January."

On AIM, t42 IoT Tracking Solutions surged 60%.

It announces a collaboration with Sateliot IOT Sefvices. Based in Barcelona, Sateliot IOT Sefvices operates a low-earth orbit 5G internet of things satellite constellation.

CEO Avi Hartmann said: "It is unbelievable what a small hardware investment can represent for the industry's performance overall. This change has come to stay; there's no doubt about it and t42 has positioned itself to be a leader in this change over the next few years."

The pound was quoted at USD1.2632 early on Friday in London, lower compared to USD1.2652 at the equities close on Thursday. The euro stood at USD1.898, lower against USD1.0909. Against the yen, the dollar was trading at JPY148.29, higher compared to JPY147.85.

In Asia on Friday, the Nikkei 225 index in Tokyo was down 0.2%. In China, the Shanghai Composite was up 0.1%, while the Hang Seng index in Hong Kong was down 1.3%. The S&P/ASX 200 in Sydney closed down 0.2%.

In the US on Thursday, Wall Street ended mixed, with the Dow Jones Industrial Average up 1.5%, the S&P 500 up 0.4% and the Nasdaq Composite down 0.2%.

In European equities on Friday, the CAC 40 in Paris and the DAX 40 in Frankfurt were both up 0.5%.

Gold was quoted at USD2,039.66 an ounce, higher against USD2,038.85.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.